![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celoxica | LSE:CXA | London | Ordinary Share | GB00B0L9TZ33 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 1905Y Celoxica Holdings PLC 03 July 2008 CELOXICA HOLDINGS PLC ("CELOXICA" OR "THE COMPANY") Directorate Change Celoxica strengthens Capital Markets expertise 3rd July 2008 - Celoxica Holdings plc (AIM: CXA) - a leading provider of accelerated, low latency computing solutions, is today delighted to announce the appointment of John Oddie to its Board as a non-executive Director. Mr. Oddie has over 25 years experience of working in the financial services sector with a particular focus on market trading, Celoxica's key target market. Until 2007, he ran the exchange business for Atos Euronext Market Solutions (AEMS), AEMS' largest business unit, which provides technology and services for global exchanges, clearing houses and capital markets. Prior to this, he was the Executive Vice President of Instinet's Global Equities business and has also held senior technology roles at Goldman Sachs, Credit Suisse and Merrill Lynch. In addition to his appointment as non-executive Director, John will also be stepping into the role of acting Chief Technology Officer for Celoxica. Lee Staines, Chief Executive of Celoxica commented, "Following the appointment of Jean-Marc Bouhelier at the end of 2007, John's extensive expertise in the financial markets makes him an ideal addition to the Board as Celoxica continues its focus on providing solutions for proprietary traders, market makers and trading exchanges. John has spent the last few months advising Celoxica on its new business strategy and his belief in our technology is a further validation of the benefits it can bring to our target market. John's guidance and experience will be highly valuable to the Company going forward." John Oddie, non-executive Director added, "Having spent my career working in financial service organisations, I am fully aware of the need for high volume data processing and especially the need for acceleration, low latency and data consistency in today's highly competitive electronic trading environments. I have been highly impressed by Celoxica's technology and believe it can provide firms in the sector with a definite competitive edge. Its solutions have the ability to make a real impact in the way data is received and then used when trading in the rapidly expanding and volatile options and cash markets. I am looking forward to helping Celoxica realise this potential." In addition to his directorship in the Company, Mr. John Charles William Marshall Oddie (54) is a Director of Asymptote Consulting Limited, a business and technical consultancy company to the finance sector, and was previously a director of SecFinex Limited, a stock loan trading application service provider. There are no further disclosures to be made in accordance with Schedule 2(g) of the AIM Rules for Companies. ENQUIRIES Celoxica Holdings plc (www.celoxica.com) Tel. +44 (0)1235 863 656 Lee Staines, CEO ICIS Tel. +44 (0) 20 7651 8688 Tom Moriarty +44 (0) 7843 260 623 Caroline Evans-Jones Arbuthnot Tel. +44 (0) 20 7012 2000 Tom Griffiths Alasdair Younie About Celoxica Celoxica is a leader in accelerated computing solutions, with a focus on low latency, high volume market data feed processing for Financial Services. Headquartered in Abingdon, Oxfordshire and New York, Celoxica is a public company quoted on AIM at the London Stock Exchange (AIM: CXA). Celoxica's solutions combine accelerated hardware, firmware, Application Programming Interfaces (APIs) and professional services to provide competitive edge to traders in today's automated and electronic trading environments. For more information, please visit the company website at www.celoxica.com. This information is provided by RNS The company news service from the London Stock Exchange END BOAELLFBVDBEBBK
1 Year Celoxica Chart |
1 Month Celoxica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions